ACRO Biomedical, a pioneering biotechnology company based in Taiwan, is proud to announce its participation in Medicall Chennai 2025, where it will unveil the ABCcolla ® Ophthalmic Matrix—a newly ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A scientific team from the University of Liège has just developed an innovative polymer, PHOx, which could significantly ...

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.

A University of Texas at Austin team has developed new resins for 3D printing materials quickly with flexibility, strength ...

Developing Class III medical devices, those that are life-sustaining, life-supporting, or implanted, presents some of the major challenges in the healthcare industry.

--The World's First Precisely Regulated Injectable CaHA Filler, Accelerating Compliance in the Medical Aesthetics Industry in China. SHANGHAI, March 21, 2025 /PRNewswire/ -- Shanghai Moyom ...

Moving forward, BCC Research projects that the global medical device industry will increase from US$810.4 billion in 2024 to US$1.3 trillion by 2029, expanding at a compound annual growth rate of ...

Eyebright Medical Technology (Beijing) Ltd (" Eyebright Medical "; SH Stock Code: 688050.SH) is a National High-tech Enterprise and state-level technologically advanced 'little giant' enterprises ...

HONG KONG, Jan. 7, 2025 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ('Eyebright Medical', the 'Company', Stock Code: 688050.SH, together with its subsidiaries collectively ...

The Loong Crystal PR intraocular lens is meticulously designed for the treatment of adult patients, providing effective correction or reduction of myopia ranging from -3.25D to -18.00D. This lens ...